This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Novamoxin (2017-11-07)

Starting date:
November 7, 2017
Posting date:
November 16, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
Healthcare Professionals, General Public, Hospitals
Identification number:
RA-65126

Affected products

Novamoxin

Reason

The homogeneity is out of specification in the affected lot.

Depth of distribution

Wholesalers and retailers (Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan)

Affected products

Novamoxin

DIN, NPN, DIN-HIM
DIN 00452149
Dosage form

Granules For Suspension

Strength

125 MG / 5 ML

Lot or serial number

35437011A

Companies
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Date modified: